ストックスクリーナーアプリを入手
4.87
4.42%
-0.225
プレマーケット:
4.81
-0.06
-1.23%
前日終値:
$5.095
開ける：
$4.91
24時間の取引高:
14,772
Relative Volume:
0.06
時価総額：
$13.03M
収益：
-
当期純損益:
$-58.52M
株価収益率:
-2.3301
EPS:
-2.09
ネットキャッシュフロー:
$-45.03M
1週間 パフォーマンス:
-0.41%
1か月 パフォーマンス:
+968.92%
6か月 パフォーマンス:
+540.79%
1年 パフォーマンス:
+212.18%
1日の値動き範囲:
$4.85
$5.28
1週間の範囲:
$4.80
$5.42
52週間の値動き範囲:
$0.224
$6.42
Nextcure Inc Stock (NXTC) Company Profile
名前
Nextcure Inc
セクター
電話
240-399-4900
住所
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
NXTC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
4.87 | 13.81M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-04 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | 開始されました | Ladenburg Thalmann | Buy |
| 2021-03-05 | アップグレード | Truist | Hold → Buy |
| 2021-01-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-07-16 | アップグレード | The Benchmark Company | Hold → Buy |
| 2020-07-13 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2020-07-13 | ダウングレード | SunTrust | Buy → Hold |
| 2020-06-01 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2020-05-26 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-03-24 | 開始されました | The Benchmark Company | Buy |
| 2020-03-02 | 開始されました | ROTH Capital | Buy |
| 2020-01-13 | 開始されました | SunTrust | Buy |
| 2019-12-05 | 開始されました | Needham | Buy |
| 2019-11-26 | 開始されました | BTIG Research | Buy |
| 2019-07-09 | 開始されました | BofA/Merrill | Buy |
| 2019-06-03 | 開始されました | Morgan Stanley | Overweight |
| 2019-06-03 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Nextcure Inc (NXTC) 最新ニュース
Does NextCure Inc. qualify in momentum factor screeningFree Consistent Income Focused Trade List - Newser
Published on: 2025-08-11 00:58:31 - Newser
Backtesting results for NextCure Inc. trading strategiesFree Short Term Trading Opportunity Watch - Newser
How NextCure Inc. stock performs during market volatilityCapital Secure Pattern Signal Analysis Sheet - Newser
NextCure Inc. Company Revenue and Profit Trends: A Deep DiveMomentum Stocks with Breakout Potential - Newser
Is it time to cut losses on NextCure Inc.Early Entry Ideas with Momentum Potential - Newser
NextCure Inc. Earnings Report Breakdown: What Investors Should KnowConservative Investment Setup and Risk Analysis - Newser
Using fundamentals and technicals on NextCure Inc.Free Stock Screener With Smart Filters - Newser
How to monitor NextCure Inc. with trend dashboardsFree Smart Trade Plans With Risk Protection - Newser
What makes NextCure Inc. stock price move sharplyFree Real Time Trade Opportunity Alerts - Newser
NextCure Reports Q2 2025 Earnings, Partners with Simcere Zaiming, and Advances Clinical Trials - AInvest
Will NextCure Inc. stock recover after recent dropSmart Swing Picks with Confirmed Signals - Newser
NextCure Inc. stock volume spike explainedFree Technical Stock Breakout Predictions - Newser
NextCure (NXTC) Q2 Loss Widens 71% - AOL.com
NextCure Reports Q2 2025 Results and Strategic Updates - TipRanks
NextCure Inc reports results for the quarter ended June 30Earnings Summary - TradingView
NextCure (NXTC) Q2 Loss Widens 71% - The Motley Fool
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results - The Manila Times
NextCure's Dual ADC Cancer Programs Progress: Strategic Partnership Fuels Clinical Advancement - Stock Titan
Short interest data insights for NextCure Inc.Long-Term Investment Strategy Impact Analysis - Newser
Why NextCure Inc. stock attracts strong analyst attentionStrong Buy Opportunity with Volume Support - Newser
What indicators show strength in NextCure Inc.Free Low Risk Picks for Daily Trading - Newser
What are the latest earnings results for NextCure Inc.Superior risk-adjusted returns - Jammu Links News
When is NextCure Inc. stock expected to show significant growthRapidly expanding wealth - Jammu Links News
What drives NextCure Inc. stock priceBreakthrough stock performance - Jammu Links News
Published on: 2025-08-03 14:04:52 - Jammu Links News
Is it the right time to buy NextCure Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
How does NextCure Inc. generate profit in a changing economyTremendous return rates - Jammu Links News
Is NextCure Inc. a good long term investmentSuperior stock growth - Jammu Links News
What institutional investors are buying NextCure Inc. stockGet daily expert analysis for smarter investing - Jammu Links News
What catalysts could drive NextCure Inc. stock higher in 2025Build a portfolio that outperforms the market - Jammu Links News
Does NextCure Inc. stock perform well during market downturnsDiscover market opportunities with real-time data - Jammu Links News
What are analysts’ price targets for NextCure Inc. in the next 12 monthsGet professional advice for portfolio optimization - jammulinksnews.com
Is NextCure Inc. Stock a Smart Buy in 2025 Investment Analysis InsideTrade Safety Report with Pattern Insights - Newser
What is the dividend policy of NextCure Inc. stockStock Strategy Insights For Consistent Profits - Jammu Links News
Nextcure Inc (NXTC) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
3.39%
大文字化:
|
ボリューム (24 時間):